tradingkey.logo
tradingkey.logo
Buscar

Stereotaxis Inc

STXS
Añadir a la lista de seguimiento
1.790USD
+0.020+1.13%
Cierre 07/02, 13:00ETCotizaciones retrasadas 15 min
174.50MCap. mercado
PérdidaP/E TTM

Más Datos de Stereotaxis Inc Compañía

Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory. Its proprietary robotic technology, Robotic Magnetic Navigation (RMN), fundamentally transforms endovascular interventions using precise computer-controlled magnetic fields to directly control the tip of flexible interventional catheters or devices. The Company’s primary products include the Genesis RMN System, the Odyssey Solution, and other related devices. Through its strategic relationships with fluoroscopy system manufacturers, providers of catheters and electrophysiology mapping systems, and other parties, the Company offers its customers x-ray systems and other accessory devices. The Genesis RMN System is designed to enable physicians to complete more complex interventional procedures by providing image-guided delivery of catheters through the blood vessels and chambers of the heart to treatment sites.

Información de Stereotaxis Inc

Símbolo de cotizaciónSTXS
Nombre de la empresaStereotaxis Inc
Fecha de salida a bolsaAug 12, 2004
Director ejecutivoFischel (David Leo)
Número de empleados139
Tipo de seguridadOrdinary Share
Fin del año fiscalAug 12
Dirección710 N Tucker Blvd
CiudadST. LOUIS
Bolsa de valoresNASDAQ OMX – NASDAQ Basic Amex
PaísUnited States of America
Código postal63101
Teléfono13146786100
Sitio Webhttps://www.stereotaxis.com/
Símbolo de cotizaciónSTXS
Fecha de salida a bolsaAug 12, 2004
Director ejecutivoFischel (David Leo)

Ejecutivos de Stereotaxis Inc

Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. David W. Benfer
Mr. David W. Benfer
Lead Independent Director
Lead Independent Director
463.30K
-19.56%
Mr. David Leo Fischel
Mr. David Leo Fischel
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
255.00K
+21.57%
Dr. Nathan Fischel, M.D.
Dr. Nathan Fischel, M.D.
Director
Director
254.50K
-12.03%
Mr. Ross B. Levin
Mr. Ross B. Levin
Independent Director
Independent Director
154.97K
-19.76%
Mr. Nachum (Homi) Shamir
Mr. Nachum (Homi) Shamir
Director
Director
136.22K
+34.46%
Dr. Arun Swarup Menawat, Ph.D.
Dr. Arun Swarup Menawat, Ph.D.
Independent Director
Independent Director
--
--
Ms. Kimberly R. Peery
Ms. Kimberly R. Peery
Chief Financial Officer
Chief Financial Officer
--
--
Dr. Myriam J. Curet, M.D.
Dr. Myriam J. Curet, M.D.
Independent Director
Independent Director
--
--
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. David W. Benfer
Mr. David W. Benfer
Lead Independent Director
Lead Independent Director
463.30K
-19.56%
Mr. David Leo Fischel
Mr. David Leo Fischel
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
255.00K
+21.57%
Dr. Nathan Fischel, M.D.
Dr. Nathan Fischel, M.D.
Director
Director
254.50K
-12.03%
Mr. Ross B. Levin
Mr. Ross B. Levin
Independent Director
Independent Director
154.97K
-19.76%
Mr. Nachum (Homi) Shamir
Mr. Nachum (Homi) Shamir
Director
Director
136.22K
+34.46%
Dr. Arun Swarup Menawat, Ph.D.
Dr. Arun Swarup Menawat, Ph.D.
Independent Director
Independent Director
--
--

Preguntas frecuentes

¿Quiénes son los cinco principales accionistas de Stereotaxis Inc?

Los cinco principales accionistas de Stereotaxis Inc son: Mr. David W. Benfer

¿Cuántas instituciones poseen acciones de Stereotaxis Inc (STXS)?

A fecha de 2026Q1, 205 instituciones poseen acciones de Stereotaxis Inc, con un valor de mercado combinado de aproximadamente 49.70M, lo que representa el 50.99% del total de acciones. En comparación con el 2025Q4, el accionariado institucional ha aumentado en 2238158.00.